# PharmaClaw Reddit Marketing Posts
*Updated 2026-04-08 by Cheminem*

Strategy: Post r/chemistry first (largest, most general), then space 2-3 days apart.
Tone: Genuine, not salesy. Lead with the problem, show the tool, invite feedback.

---

## Post 1: r/chemistry
**Target:** Broad chemistry audience, academics + industry
**When:** First

**Title:** I built an open-source AI pipeline that chains 11 agents to analyze drug candidates — from SMILES to full report

**Body:**
Hey r/chemistry,

I've been working on something called PharmaClaw — an AI-powered drug discovery pipeline that takes a SMILES string and runs it through 11 specialized agents:

- **Chemistry** — molecular properties, descriptors, 2D viz (RDKit)
- **Cheminformatics** — 3D conformers, pharmacophores, RECAP fragmentation
- **ADME/PK** — Lipinski, Veber, QED, BBB, solubility, CYP inhibition
- **Toxicology** — PAINS alerts, structural flags, risk classification
- **ADMET Prediction** — ML-based absorption, distribution, metabolism, excretion, toxicity
- **Synthesis** — retrosynthetic routes, BRICS disconnections
- **Catalyst Design** — organometallic catalyst recommendation + novel ligand design
- **Literature** — PubMed + Semantic Scholar search
- **IP Analysis** — FTO assessment, patent similarity, bioisostere suggestions
- **Market Intel** — FDA FAERS adverse event data
- **Protein-Ligand Docking** — AutoDock Vina pipeline

Everything chains together — toxicology findings feed into IP suggestions, synthesis routes inform catalyst selection, etc. The output is a consensus score (0-10) with actionable recommendations.

The two core agents (Chemistry + Pharmacology) are free and open source. There's also a $99 report service if you just want to submit a SMILES and get a PDF back.

**Live demo:** Every Wednesday we design a novel molecule and run it through the full pipeline → [pharmaclaw.com](https://pharmaclaw.com) (Molecule of the Week)

**Sample report:** [Download PDF](https://pharmaclaw.com/sample-report.pdf)

Would love feedback from actual chemists. What would make this more useful for your work?

---

## Post 2: r/drugdiscovery
**Target:** Drug discovery professionals, pharma researchers
**When:** 2-3 days after Post 1

**Title:** Built an 11-agent AI pipeline for lead compound analysis — ADME, tox, synthesis, IP, docking — all from a SMILES string

**Body:**
For the past few months I've been building PharmaClaw, an AI pipeline specifically for drug discovery workflows. The idea: you give it a SMILES string and a disease target, and 11 specialized agents analyze it end-to-end.

**What it actually does:**

1. Molecular profiling (RDKit — properties, descriptors, standardization)
2. 3D cheminformatics (conformers, pharmacophores, RECAP)
3. ADME/PK (Lipinski, BBB, solubility, CYP inhibition, bioavailability)
4. ML-based ADMET prediction (HIA, Caco-2, hERG, DILI, Ames)
5. Safety profiling (PAINS, structural alerts, risk classification)
6. Retrosynthesis + catalyst recommendation
7. Literature mining (PubMed + Semantic Scholar)
8. IP/FTO analysis with bioisostere suggestions
9. Market intelligence (FDA FAERS adverse events)
10. Protein-ligand docking (AutoDock Vina)
11. Consensus scoring with recommendations

The agents share context — if tox flags something, IP automatically suggests safer derivatives. If synthesis identifies reaction types, catalyst design picks optimal conditions.

**Not trying to replace med chemists** — this is meant to be the first 30 minutes of analysis that takes hours to do manually, automated into a single run.

Two agents are free (Chemistry + Pharmacology). Full pipeline available as a $99 report: [pharmaclaw.com/order.html](https://pharmaclaw.com/order.html)

Sample output: [pharmaclaw.com/sample-report.pdf](https://pharmaclaw.com/sample-report.pdf)

Curious what drug discovery folks think — what's missing? What would you actually use this for?

---

## Post 3: r/cheminformatics
**Target:** Technical cheminformatics community
**When:** 2-3 days after Post 2

**Title:** PharmaClaw — 11 chained AI agents for compound analysis (RDKit + PubChem + AutoDock Vina + LangGraph orchestration)

**Body:**
Sharing a project I've been building: PharmaClaw — a multi-agent pipeline for drug candidate analysis.

**Technical stack:**
- RDKit for all molecular computations (properties, conformers, pharmacophores, RECAP, fingerprints)
- PubChem API for compound data
- AutoDock Vina for protein-ligand docking
- openFDA API for FAERS adverse event data
- PubMed + Semantic Scholar APIs for literature
- LangGraph (LangChain) for stateful multi-agent orchestration
- Python CLI with JSON piping between agents

**The 11 agents:**
Chemistry Query → Cheminformatics → Pharmacology → ADMET Prediction → Toxicology → Synthesis → Catalyst Design → Literature → IP Expansion → Market Intel → Consensus

Each agent reads from and writes to a shared context (molecule_profile, findings, open_questions). The orchestrator uses conditional routing — e.g., high tox score triggers pharmacology re-optimization.

**What's interesting technically:**
- Context-aware pipeline: agents build on each other's findings, not just running in sequence
- Bioisostere generation when IP risk is high (automatic derivative suggestions)
- Catalyst recommendation reads actual reaction types from retrosynthesis (not hardcoded)
- RECAP fragmentation feeds into scaffold analysis for IP novelty

The core Chemistry + Pharmacology agents are free on ClawHub. Full pipeline reports: [pharmaclaw.com](https://pharmaclaw.com)

Source on GitHub: [CheminemPharmaclaw/pharmaclaw](https://github.com/CheminemPharmaclaw/pharmaclaw)

What cheminformatics capabilities would you add? Thinking about AiZynthFinder integration and ChemProp for ML property prediction next.

---

## Post 4: r/MachineLearning
**Target:** ML/AI audience, focus on the multi-agent architecture
**When:** 2-3 days after Post 3

**Title:** [P] Multi-agent drug discovery pipeline — 11 specialized LLM agents with shared context and conditional routing

**Body:**
Sharing a project that uses multi-agent orchestration for drug discovery: **PharmaClaw**

**Architecture:**
- 11 specialized agents, each wrapping domain-specific tools (RDKit, PubChem, AutoDock Vina, PubMed, openFDA)
- LangGraph (LangChain) StateGraph for orchestration with typed state
- Shared context: agents read/write to molecule_profile, findings, and open_questions
- Conditional routing: high toxicity → re-route to pharmacology for optimization; high IP risk → auto-generate bioisosteres

**Why multi-agent instead of one big prompt?**
Each agent is a focused expert with specific tools. The chemistry agent knows RDKit inside-out. The literature agent knows PubMed APIs. Keeping them separate means:
- Each agent can use a different model (we use fast models for structured tasks, better models for orchestration)
- Failures are isolated — if literature search times out, the rest of the pipeline still completes
- New capabilities plug in without rewriting everything

**Pipeline flow:**
Chemistry → Cheminformatics → Pharmacology → ADMET → Toxicology → Synthesis → Catalyst Design → Literature → IP → Market Intel → Consensus (scoring + recommendations)

**What I learned:**
- Shared mutable context between agents is powerful but needs careful schema design
- LLM-generated SMILES are unreliable — always validate with RDKit before passing downstream
- The "consensus" step works best when it has accumulated findings from all agents, not just final outputs
- Cost per full run: ~$2-3 in API calls

Demo + sample report: [pharmaclaw.com](https://pharmaclaw.com)

Happy to discuss the multi-agent architecture or the domain-specific challenges.
